Blood test may spot hidden cancer relapses in HPV pelvic cancer survivors

NCT ID NCT03739775

Ongoing Diagnosis Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 24 times

Summary

This study looks at whether a simple blood test that finds tumor DNA can detect the return of HPV-positive pelvic cancers (like cervical or anal cancer) earlier than usual scans or exams. About 172 people who finished curative treatment for stage II or III disease will give blood samples during follow-up visits. The goal is to see how accurate the test is at spotting relapses within 6 months, which could help doctors act faster.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV POSITIVE PELVIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

CHU Pontchaillou

Rennes, 35033, France
CHU de Besançon

Besançon, 25030, France
Hôpital Tenon

Paris, 75020, France
Institut Curie - Paris

Paris, 75005, France
Institut Curie - Saint-Cloud

Saint-Cloud, 92210, France

Conditions

Explore the condition pages connected to this study.

HPV POSITIVE PELVIC CANCER